Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01511081 · ClinicalTrials.gov registry record · Phase 2
Stereotactic Body Radiotherapy (SBRT) Versus Stereotactic Body Proton Therapy (SBPT)
A Phase 2 study, sponsored by M.D. Anderson Cancer Center.
- Terminated
- Registry status
- Phase 2
- Development phase
- 21
- Enrollment target
NCT01511081: Clinical Trial Phase 2 study, sponsored by M.D. Anderson Cancer Center.
NCT01511081 is a Phase 2 study that was terminated before completion, run by M.D. Anderson Cancer Center. The registered enrollment target is 21 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01511081, a Phase 2 study, was terminated before completion, sponsored by M.D. Anderson Cancer Center.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 21 participants
- Enrollment target
Study Summary
The goal of this clinical research study is to compare 2 types of radiotherapy, stereotactic body photon radiotherapy (SBRT) and stereotactic body proton radiotherapy (SBPT). Researchers would like to compare the side effects, quality of life, and cancer control.
Interventions
- RADIATION SBRT (stereotactic body radiotherapy)
- RADIATION SBPT (stereotactic body proton therapy)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2012-08 |
| Est. Completion | 2016-10 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01511081
The ClinicalTrials.gov registry entry for NCT01511081 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which SBRT (stereotactic body radiotherapy) is the first listed.
NCT01511081 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01511081 about?
NCT01511081 is a clinical study titled "Stereotactic Body Radiotherapy (SBRT) Versus Stereotactic Body Proton Therapy (SBPT)". The goal of this clinical research study is to compare 2 types of radiotherapy, stereotactic body photon radiotherapy (SBRT) and stereotactic body proton radiotherapy (SBPT). Researchers would like to compare the side effects, quality of life, and cancer control.
What is the current status of trial NCT01511081?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 21 participants. The study started on 2012-08. Estimated completion is 2016-10.
What interventions are being tested in trial NCT01511081?
The interventions under investigation include: SBRT (stereotactic body radiotherapy) (RADIATION), SBPT (stereotactic body proton therapy) (RADIATION).
Who is sponsoring clinical trial NCT01511081?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.